Clinical Trial: Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma

Clinical Trial: Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma

Sponsor and Collaborators

Boston VA Research Institute, Inc.
Millennium Pharmaceuticals, Inc.

Contact
Contact: Nikhil C. Munshi, M.D.
617-632-5607
nikhil_munshi@dfci.harvard.edu

Contact: Saem Lee
857-203-5146
saem.lee@va.gov

Principal Investigator
Nikhil C. Munshi, M.D. Boston VA Research Institute, Inc.

ClinicalTrials.gov Identifier
NCT01090921
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs